Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Søren Lund Kristensen
ResearcherPublications, citations & collaboration network
Søren Lund Kristensen is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 220 works, 10,060 citations, an h-index of 47 and an i10-index of 96.
220
Works
10,060
Citations
47
h-index
96
i10-index
How has Søren Lund Kristensen's publication output changed over time?
ScholarIQpublication output · 2012–2021
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2021.
1
2
2
1
1
2
1
1
20122013201620172018201920202021
What are the most-cited papers on Søren Lund Kristensen?
ScholarIQmost cited works
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, Kieran F. Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C. Petrie, John J.V. McMurray
The Lancet Diabetes & Endocrinology. 20191,642 CitationsOPEN ACCESS
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato, Nardev S. Khurmi, Carolyn S.P. Lam, Renato D. Lópes, John J.V. McMurray, Richard E. Pratley, Julio Rosenstock, Hertzel C. Gerstein
The Lancet Diabetes & Endocrinology. 20211,549 CitationsOPEN ACCESS
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
Morten Lamberts, Jonas Bjerring Olesen, Martin H. Ruwald, Carolina Malta Hansen, Deniz Karasoy, Søren Lund Kristensen, Lars Køber, Christian Torp‐Pedersen, Gunnar Gislason, Morten Lock Hansen
Circulation. 2012418 CitationsOPEN ACCESS
Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Søren Lund Kristensen, David Preiss, Pardeep S. Jhund, Iain Squire, José Silva‐Cardoso, Béla Merkely, Felipe A. Martínez, Randall C. Starling, Akshay S. Desai, Marty Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile, John J.V. McMurray, Milton Packer
Circulation Heart Failure. 2016352 CitationsOPEN ACCESS
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
Morten Lamberts, Gunnar Gislason, Jonas Bjerring Olesen, Søren Lund Kristensen, Anne‐Marie Schjerning Olsen, Anders Pretzmann Mikkelsen, Christine Benn Christensen, Gregory Y.H. Lip, Lars Køber, Christian Torp‐Pedersen, Morten Lock Hansen
Journal of the American College of Cardiology. 2013338 CitationsOPEN ACCESS
Related on ScholarIQ
University of Copenhagen
Institution
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Paper
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Paper
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
Paper
Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Paper
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
Paper